№ 3 / 2014 / 72-75

Diabetic retinopathy and hypertension: clinical and pathophysiological aspects of comorbidity and rational drug correction

Abstract

This article assesses the role of hypertension in the progression of diabetic retinopathy and possible rational therapeutic approaches, as well as features of the influence of angiotensin converting enzyme (ACE) inhibitors being to reduce endothelial dysfunction. Review of the current literature confirms the importance and desirability of developing an effective method of drug correction and prevention of progression of diabetic retinopathy in hypertensive patients through the use of ACE inhibitors.

Key words

arterial hypertension, diabetic retinopathy, ACE inhibitors, pathophysiology, diabetes mellitus

References

1. Astaxov Yu.S., Shadrichev F.E., Lisochkina A.B. Diabetic retinopathy // Clinical guidelines. Ophthalmology / Eds. L.K. Moshetov, A.P. Nesterov, E.A. Egorov. Мoscow: GEOTAR-Media, 2006. 139–163. (in Russian)

2. Astaxov Yu.S., Shadrichev F.E., Lisochkina A.B. Diabetic retinopathy // Klinicheskaya oftalmologiya. 2004. 5. (2). 85–92. (in Russian)

3. Balabolkin M.I., Kreminskaya V.M., Klebanova E.M. Role of endothelial dysfunction and oxida-tive stress in the mechanisms of angiopathy in type 2 diabetes // Kardiologiya. 2004. (7). 90–97. (in Russian)

4. Gadjieva A. M. Medico-social aspects of disability due to eye pathology in diabetes: abstract of thesis …candidate of medical sciences. Moscow, 1993. (in Russian)

5. Didenko V.A., Simonov D.V. Communication insulin concentration in the blood with the renin-angiotensin-aldosterone system, and the clinical picture of hypertension // Terapevticheskiy arkhiv. 1999. (1). 26–31. (in Russian)

6. Didenko V.A. Pathogenesis, clinical course and treatment of hypertension associated with metabolic syndrome: abstract of thesis…doctor of medical sciences. Moscow, 2001. (in Russian)

7. Zimin Yu.V. Origin, diagnostic and clinical significance of the concept of insulin resistance syndrome or metabolic syndrome X // Kardiologiya. 1998. (6). 71–81. (in Russian)

8. Maltsev E.B., Rodin S.S., Chernyaeva S.N., Maxmud M.R. Diabetic retinopathy: mechanisms of development // Oftalmologicheskiy zhurnal. 2003. (2). 82–88. (in Russian)

9. Polivoda S.N. Von Willebrand factor as a marker of endothelial dysfunction in patients with diseases of the cardiovascular system // Ukrainskiy revmatologicheskiy zhurnal. 2000. (1). 13–17. (in Russian)

10. Preobrajenskii D.V. Fosinopril is the first representative of a new generation of angiotensin convert-ing enzyme inhibitors // Kardiologiya. 2000. (5). 75–82. (in Russian)

11. Preobrajenskii D.V. Successes and failures in the development of new approaches to drug therapy of chronic heart failure // Kardiologya. 2000. (4). 67–76. (in Russian)

12. Suntsov Yu.I., Kudryakova S.V., Bolotskaya L.L. Meaning of the State Register of diabetics in the development of the diabetes service // Sakharnyi diabet. 2002. (1). 28–31. (in Russian)

13. Chazova I.E. The use of ACE inhibitors for treatment of hypertension // Russkii meditsinskii jurnal. 2000. (15–16). 610–613. (in Russian)

14. Shadrichev F.E. Diabetic retinopathy // Sovremennaya optometriya. 2008. (4). 36–42. (in Russian)

15. Dzau V.J., Gibbons G.H., Pratt R.E. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia // Hypertension. 1991. 18 (4). 100–105.

16. Klein R., Klein B., Moss S. et al. The Wisconsic epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes // Ophthalmology. 1998. 105 (10). 1801–1815.

17. Lithell H.O. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism // Diabetes Care. 1991. 14. (3). 203–209.

18. Mahtab H., Kibriya M.G., Mahtab F.U. Microvascular complications in Bangladeshi type-2 diabetic individuals: Birdem Diabetes Care and Complication Study // Diabetologia. 2001. 44. (1). 285.

19. Stratton I.M., Adler A.I., Neil A.W. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // Br. Med. J. 2000. 321. 405–412.

20. Thomann U., Buchi E.R., Suppiger M. et al. Age-dependent phenotypic expression of a pattern dystrophy of the retina // Eur. J. Ophthalmol. 1995. (5). 107–112.

21. Turner R.C., Millns H., Neil H.A.W. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS 23) // Br. Med. J. 1998. 316. 823–828.

22. UK Prospective Diabetes Study: UKPDS VIII. Study design, progress and performance // Diabetologia. 1991. 34. (12). 877–890.

23. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee // J. Hypertens. 1999. 17. 151–183.

24. Zicchelli P. Calcium channel blockers in diabetic nephropathy is there life after the ABCD trial Nephrol // Dial. Transplant. 1998. 13. 1930–1932.

About Authors (Correspondence):

Hodjaev N.S. – doctor of medical sciences, professor, head of the centre for scientific and clinical work

Kuntysheva K.E. – postgraduate student, email: ksenia-ek@yandex.ru

Full Text

12-3-2014.pdf

Received: 10/02/2015